ELPEN PHARMA GmbH is the subsidiary of ELPEN at Germany. It was established in February 2012 aiming to be ELPEN's strategic development center for Europe.
ELPEN Pharma GmbH develops significant commercial activity in promotion of the following products Rolenium® Elpenhaler® και Pulmelia® Elpenhaler®.
ELPEN is established in German market as a trustworthy provider of pharmaceutical treatments. In this context, it maintains exclusive contracts with the insurance funds of Germany, which make the above products exclusively prescribed for the specific combinations of active substances.
ELPEN Pharma GmbH employs more than twenty (20) experienced professionals in the pharmaceutical industry in the roles of General Management, Marketing and Sales.
For more information about ELPEN Pharma GmbH click here.
ELPEN Pharma GmbH
Bismarckstr. 63
12169 Berlin-Steglitz
Tel.: +49 30 79740400
Fax +49 30 7974040-17
www.elpen-pharma.de